SCHEMBL1936873

SCHEMBL1936873

Clc1ncc(Cl)c(NC2COC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.46
AXL P30530 1/20 0.38
MAT2A P31153 1/20 0.34
JAK2 O60674 5/20 0.34
JAK1 P23458 4/20 0.34
LRRK2 Q5S007 3/20 0.34
MAPK1 P28482 1/20 0.33
FLT3 P36888 2/20 0.32
AURKB Q96GD4 1/20 0.32
SELP P16109 1/20 0.32
TYRO3 Q06418 1/20 0.32
STK17B O94768 1/20 0.32
STK17A Q9UEE5 1/20 0.32
ADORA3 P0DMS8 2/20 0.32
ADORA2A P29274 2/20 0.32
ADORA2B P29275 2/20 0.32
ADORA1 P30542 2/20 0.32
AURKA O14965 1/20 0.32
TYK2 P29597 1/20 0.32
JAK3 P52333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844926 0.84 KMT2A (0.58) KMT2AAXLJAK2JAK1MAPK1
SCHEMBL21593640 0.83 KMT2A (0.44) KMT2AAXLMAT2AMAPK1ADORA3
SCHEMBL1934159 0.81 KMT2A (0.69) KMT2AAXLADORA3ADORA2AADORA2B
SCHEMBL993784 0.81 KMT2A (0.64) KMT2AAXLLRRK2ADORA3ADORA2A
SCHEMBL22998017 0.80 ULK1 (0.50) KMT2ALRRK2
SCHEMBL21409882 0.80 CSNK1A1 (0.45) KMT2AAXLMAT2ALRRK2AURKA
SCHEMBL30662127 0.80 CSNK1A1 (0.45) KMT2AAXLMAT2ALRRK2AURKA
SCHEMBL17196763 0.79 KMT2A (0.46) KMT2AAXLJAK2JAK1FLT3
SCHEMBL1937546 0.79 KMT2A (0.71) KMT2AAXLADORA3ADORA2AADORA1
SCHEMBL1936351 0.78 KMT2A (0.45) KMT2AAXLJAK2JAK1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110245242-A1 Heterocyclically Substituted Anilinopyrimides BAYER CROPSCIENCE AG (DE) 2011-10-06 US disclosed
EP-2331524-A1 HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES Bayer CropScience AG (DE) 2011-06-15 EP disclosed
WO-2010025831-A1 HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES BAYER CROPSCIENCE AG (DE) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245242-A1 Heterocyclically Substituted Anilinopyrimides H1-10, POLL, PPM1D KMT2A 1011/4885AXL 840/4885MAT2A 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.